NCT01217528

Reduction of Inappropriate Implantable Cardioverter Defibrillator (ICD) Therapies in Primary Prevention Patients

Reduction of Inappropriate ICD Therapies in Patients With Approved Indication for Primary Prevention of Sudden Cardiac Death

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 543 (actual)
• Sponsor: Abbott Medical Devices · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine efficacy of a dedicated programming concept for avoidance of inappropriate implantable cardioverter defibrillator (ICD) therapies in patient with primary prevention ICD indication.

Detailed description

Inappropriate ICD therapies still remains a major issue with respect to patient's quality of life and proarrhythmic risk. It's the aim of this study to determine efficacy of a dedicated programming concept for avoidance of inappropriate ICD therapy in patients who received the ICD for primary prevention of sudden cardiac death.

Conditions

• Cardiac Death

Interventions

Type	Name	Description
DEVICE	device settings for group A	VT zone: 350ms VF zone: 280ms
DEVICE	Device settings for group B	VT zone: 320ms VF zone: 250ms

Timeline

• Start date: 2009-08-01
• Primary completion: 2012-09-01
• Completion: 2013-01-01
• First posted: 2010-10-08
• Last updated: 2019-02-04

Locations

34 sites across 1 country: Germany